In the ongoing battle against bacterial infections, compounds like Bacilysin play a pivotal role. Known for its potent antibacterial activity, Bacilysin, identified by CAS number 1395-22-8, is a dipeptide antibiotic derived from Bacillus subtilis. Its specific mechanism of action and availability as a research chemical make it an essential tool for scientists engaged in antimicrobial discovery and development.

Bacilysin's effectiveness lies in its ability to inhibit glucosamine 6-phosphate synthase, an enzyme crucial for the synthesis of peptidoglycan, a vital component of the bacterial cell wall. This targeted inhibition disrupts bacterial integrity, leading to cell death. Researchers often seek to buy Bacilysin to study this mechanism in detail, explore its potential as a lead compound for new antibiotics, or to investigate bacterial resistance patterns. The precise chemical makeup of Bacilysin, including its molecular formula C12H18N2O5 and molecular weight of 270.283, ensures its utility in highly specific biochemical assays.

As a metabolite produced by Bacillus subtilis, Bacilysin represents a natural solution to microbial challenges. The biotechnological production of this compound, often facilitated by manufacturers in China, ensures a reliable supply for research institutions worldwide. These suppliers provide crucial support to the scientific community by offering high-purity Bacilysin, enabling breakthroughs in understanding and combating bacterial pathogens. The ability to readily access such compounds is fundamental to accelerating R&D timelines.

The continued investigation into Bacilysin, including its synthesis, activity, and potential therapeutic applications, underscores its importance in modern antibacterial research. By understanding and utilizing compounds like Bacilysin CAS 1395-22-8, scientists are better equipped to develop innovative strategies to address the growing threat of antibiotic resistance and improve global health outcomes.